Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GLAUKOS Corp Director's Dealing 2021

Feb 11, 2021

31074_dirs_2021-02-11_081740c2-05c7-43e2-95a4-d42531080a37.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GLAUKOS Corp (GKOS)
CIK: 0001192448
Period of Report: 2021-02-09

Reporting Person: Gilliam Joseph E (CFO, SVP Corporate Development)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-02-09 Common Stock M 3750 $30.92 Acquired 46552 Direct
2021-02-09 Common Stock M 10000 $41.69 Acquired 56552 Direct
2021-02-09 Common Stock S 11488 $96.49 Disposed 45064 Direct
2021-02-09 Common Stock S 2262 $97.02 Disposed 42802 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-02-09 Stock Options (Right to Buy) $30.92 M 3750 Disposed 2028-03-14 Common Stock (3750) Direct
2021-02-09 Stock Options (Right to Buy) $41.69 M 10000 Disposed 2027-05-05 Common Stock (10000) Direct

Footnotes

F1: Includes 21,107 restricted stock units that have not yet vested or been delivered to the Reporting Person.

F2: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices.

F3: This transaction was executed in multiple trades at prices ranging from $95.91 to $96.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: This transaction was executed in multiple trades at prices ranging from $96.92 to $97.24. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5: These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years.